Physical Activity, Body Composition, Serum Myokines and the Risk of Death in Hemodialysis Patients

Medicina (Kaunas). 2023 Nov 16;59(11):2020. doi: 10.3390/medicina59112020.

Abstract

Background and Objectives: The aim of this study was to assess the relationship between habitual physical activity, body composition, serum myokine concentration, and all-cause mortality in chronic hemodialysis patients. Materials and Methods: A prospective cohort study with a 7-year follow-up was conducted in a group of 38 patients (24 men, 14 women, mean age 65.6 ± 13.9 years, dialysis vintage 1.17 ± 1.25 years). Baseline serum concentrations of myokines-follistatin and myostatin-were assessed along with a measurement of physical activity with multidimensional accelerometery, body composition, and the force of forearm muscle contraction. Survival analysis was performed using the Kaplan-Meier method for tertiles of follistatin, serum myostatin, body composition, and physical activity expressed in metabolic equivalents (MET). Results: The mean physical activity among patients was 81 min/24 h (median 38.5 min), and the mean weekly 3MET activity was 493 min (median 218 min). The probability of survival of patients was significantly lower in the subgroup with 3MET/24 h less than 26 min/24 h and 3METt less than 148 min per week compared to the other subgroup (p = 0.006 and p = 0.006, respectively). During the 70-month follow-up, the subgroup with the lowest baseline follistatin concentration showed a significantly lower risk of death (p = 0.02). Baseline myostatin levels were not significant risk factors for mortality, nor were BMI or lean and fat tissue index categories. Conclusions: Physical activity and low plasma follistatin, but not body composition indexes or plasma myostatin, could serve as predictors of all-cause mortality in hemodialysis patients.

Keywords: body composition; hemodialysis; myokines; physical activity.

MeSH terms

  • Aged
  • Body Composition
  • Exercise
  • Female
  • Follistatin
  • Humans
  • Male
  • Middle Aged
  • Myostatin*
  • Prospective Studies
  • Renal Dialysis* / adverse effects
  • Risk Factors

Substances

  • Myostatin
  • Follistatin

Grants and funding

This research received no external funding.